Introduction
============

Indole alkaloids containing a 3α-amino-hexahydropyrrolo-\[2,3-*b*\]indole scaffold are present in a wide range of natural compounds ([Fig. 1](#fig1){ref-type="fig"}).[@cit1] Structurally, these indole alkaloids feature the linkage of two or more tryptamines or tryptamine derivatives *via* C3a--N1 bond formation. Due to their unique structures and versatile biological activities these compounds have attracted significant interest from synthetic chemists. For example, psychotrimine (**1**) was first isolated by the Takayama group and later synthesized by Takayama, Baran and other groups.[@cit2],[@cit3] It exhibits antibacterial activity against Gram-positive bacteria through membrane disruption.[@cit4] Chetomin (**5**) is a potential anti-cancer agent against the transcription factor hypoxia inducible factor 1 (HIF-1).[@cit5] Williams and co-workers have made great progress in the biosynthesis of chetomin.[@cit5e] Psychotetramine (**3**) was the first reported alkaloid bearing C3--C3, C7--N1 and C3a--N1 linkages. It was isolated by the Takayama group and its structure was recently elucidated by Baran *et al.*[@cit6] Among other alkaloids in this family, psychotriasine (**2**) was isolated by the Hao group,[@cit7] while pestalazine B (**4**) was isolated by the Che group and its total synthesis and structural revision was completed by de Lera and co-workers.[@cit8]

![Compounds containing the 3α-amino-hexahydropyrrolo\[2,3-*b*\]indole core.](c5sc00338e-f1){#fig1}

To develop a unified strategy for the total synthesis of these C--N linked indole alkaloids, we needed to establish a highly efficient method for rapid construction of the 3α-amino-hexahydropyrrolo\[2,3-*b*\]indole core structure. To date, a number of synthetic approaches to this core structure have been developed and are summarized in [Fig. 2](#fig2){ref-type="fig"}: (a) a well-designed method that involves a BINOL-derived chiral phosphoric acid catalyzing the addition of tryptamine derivatives with DEAD was achieved by Antilla and his colleagues;[@cit9] (b) an elegant approach to form a C--N bond through coupling of tryptamine derivatives with aniline in the presence of appropriate oxidants was accomplished independently by the Baran and Ji groups;[@cit3b],[@cit3d],[@cit6],[@cit10] (c) a nitrene-induced aziridination followed by a ring-opening and imine cyclization cascade reaction was developed by Dauban and co-workers, which readily afforded 3α-amino-hexahydropyrrolo\[2,3-*b*\]indole derivatives;[@cit11] (d) a recent report by the Rainer group on an expeditious synthesis of 3α-indole-hexahydropyrrolo\[2,3-*b*\]indole *via* the cyclopropane ring-opening process was disclosed;[@cit12] (e) an early report on an acid-catalyzed nucleophilic substitution reaction on the indole nitrogen was described by the Somei group.[@cit13]

![Reported synthetic methods for the 3α-amino-hexahydropyrrolo\[2,3-*b*\]indole core structure (a--e) and our approach in this publication and others[@cit14] (f).](c5sc00338e-f2){#fig2}

Most recently, hinging on their signature work on phase transfer catalysis, the Toste group reported a highly enantioselective (up to 96% ee) reaction to construct C3-diazenated pyrroloindolines *via* a chiral anion phase transfer process ([Fig. 2f](#fig2){ref-type="fig"}).[@cit14] This elegant work once again demonstrated the beauty of the chiral anion pair concept in asymmetric catalysis. Shortly after, the Larionov group disclosed a racemic version of this reaction.[@cit14b] However, this capable method to construct the 3α-amino-hexahydropyrrolo\[2,3-*b*\]indole scaffold was not available when we started the current investigation of our total syntheses. Thus, we have independently pursued the strategy of stereoselective domino azo-coupling/iminium cyclizations with N~a~--H tryptomine derivatives as a key step for our total synthesis design. In particular, our methodology development includes an enantioselective azo-coupling catalysis that was very similar to the Toste group\'s approach, as well as a new process of solvent-enabled diastereo-selective azo-coupling. Both methods allowed us to readily prepare C3-diazenated pyrroloindoline structural motifs *via* a cascade process. This intermediate could then be subjected to reducing conditions, and the desired 3α-aminohexahydro-pyrrolo\[2,3-*b*\]indole scaffold would be synthesized. Herein we report the successful application of these stereoselective cascade processes in the total syntheses of (--)-psychotriasine (**2**) and (+)-pestalazine B (**4**). These results demonstrate their utility as a unified strategy to synthesize such indole alkaloids.

Results and discussion
======================

Diazonium salts can be generally utilized as nitrogen sources in organic synthesis. A prominent example of their synthetic application was described in Fukuyama\'s total synthesis of mersicarpine.[@cit15] Similar to Toste\'s study, we envisioned that the chiral ion pair[@cit16]--[@cit18] which was generated by mixing diazonium salts, Na~2~CO~3~ and chiral phosphoric acid,[@cit19] would couple with tryptamine derivatives to form iminium intermediates. We anticipated that iminium cyclization would then occur to yield the azo compound in an enantioselective or diastereoselective fashion, which was the precursor of 3α-amino-hexahydropyrrolo\[2,3-*b*\]indole ([Fig. 2f](#fig2){ref-type="fig"}).

We explored the above strategy using N~a~--H tryptamine derivative **6a** (R = CO~2~Me) and PhN~2~BF~4~ as the model substrates ([Scheme 1](#sch1){ref-type="fig"}). Initially (*S*)-TRIP[@cit20] was used as the chiral phosphoric acid catalyst (**CPA8a**) at 0 °C in different solvents (for details see ESI, S-Table 1[†](#fn1){ref-type="fn"}). We were encouraged by the formation of desired product **7a** in good yields and moderate er (up to 67 : 33) in ethereal solvents such as *t*-BuOMe. Those results demonstrated that it was possible to construct the target core structure in high enantioselectivity by the chiral ion pair strategy. When switching the N-protecting group from CO~2~Me to Cbz, Boc or Bz, we found that the Bz-protected product **7d** was formed with the highest enantioselectivity (27 : 73 er). Further screening of the reaction parameters showed a slight increase in enantioselectivity at a lower temperature of --40 °C (25 : 75 er), while using other CPA (**8b--e**) catalysts led to similar or lower enantioselectivity. To our surprise, when we used 0.01 equiv. of pyridine as an additive, the enantioselectivity was increased to 20 : 80 er (CPA: **8a**). Replacing pyridine with lutidine gave similar results, and using 2,6-di-*t*-butylpyridine led to further improvement of enantioselectivity to 14.5 : 85.5 er. Presumably, a more compact and lipophilic ion pair may result in a higher enantioselectivity, and pyridine-type additives may be involved in the formation of tight ion pairs. Further optimization of the reaction conditions was achieved by applying 4-CF~3~-PhN~2~BF~4~ as the diazonium salt instead of PhN~2~BF~4~ and lowering the reaction temperature to --60 °C to obtain product **7f** in quantitative yield and 7.5 : 92.5 er (CPA: **8a**). Additional purification of **7f** by recrystallization in petroleum ether led to 69% yield and \>96% ee. Our findings, in retrospection, are in good agreement with the results of the Toste group.

![Enantioselective azo-coupling of tryptamine derivatives.](c5sc00338e-s1){#sch1}

With the core structure of 3α-amino-hexahydropyrrolo\[2,3-*b*\]indole **7f** obtained in high ee, we strived to complete the enantioselective total synthesis of natural product (--)-psychotriasine (**2**). Our retrosynthetic analysis is illustrated in [Scheme 2](#sch2){ref-type="fig"}; we proposed that (--)-psychotriasine could be readily achieved *via* several functional transformations from N~a~-Boc protected compound **9**. Compound **9** could be constructed by a Pd-catalyzed Buchwald--Hartwig amination followed by Larock annulation from the amino compound **10**. Lastly, amine **10** could be synthesized from compound **7f** through a few simple manipulations.

![Retrosynthetic analysis of (--)-psychotriasine (**2**).](c5sc00338e-s2){#sch2}

Based on the retrosynthetic analysis, our total synthesis of (--)-psychotriasine began with **7f** which was readily accomplished using our newly developed method ([Scheme 3](#sch3){ref-type="fig"}). The indole nitrogen in compound **7f** was first protected with Boc in the presence of NaHMDS and Boc~2~O at --60 °C under argon. However, subsequent cleavage of the *N*,*N* double bond was not trivial, and very poor results were acquired when we tried a variety of reductive cleavage conditions including hydrogenolysis with H~2~ under different pressures and temperatures, and even reduction with TiCl~3~/NaOH. We then attempted using hydrazine hydrate in the presence of RANEY® nickel, and it was discovered that only when excess hydrazine hydrate and a catalytic amount of RANEY® nickel were utilized could the desired product **10** be obtained in a satisfactory yield over 2 steps (88%).[@cit21],[@cit22] Compound **10** was coupled with 1,2-dibromobenzene in the presence of a Pd(OAc)~2~ catalyst, xantphos ligand and *t*-BuONa as base additive to afford the Buchwald--Hartwig amination product **11** in 71% yield.[@cit23] Next, the tryptamine dimer compound **9** was obtained *via* Larock cyclization from **11** and a known alkyne building block (*N*-(methoxycarbonyl)-4-(trimethylsilyl)-3-butynylamine) **13** ([@cit24]) using a Pd(OAc)~2~ catalyst, D^*t*^BPF ligand, K~2~CO~3~ additive and NMP solvent in 83% yield.[@cit25] N-deprotection for Bz removal with DIBAL-H[@cit26] followed by carbamation of the amine with ClCO~2~Me gave **12** in 64% yield over 2 steps. Finally, N-deprotection of **12** to remove the Boc group with CF~3~CO~2~H and further reduction with Red-Al provided the desired natural product (--)-psychotriasine (**2**) in \>96% ee.[@cit3b] With an overall yield of 11.7% over 9 steps, this procedure represents the first enantioselective total synthesis of (--)-psychotriasine.

![Total synthesis of (--)-psychotriasine (**2**). Reagents and conditions: (a) (i) NaHMDS, Boc~2~O, THF, --60 °C; (ii) RANEY® nickel, hydrazine hydrate, MeOH, sealed tube, 70 °C, 88% yield over 2 steps; (b). Pd(OAc)~2~ (0.2 equiv.), xantphos (0.3 equiv.), *t*-BuONa (2.0 equiv.), toluene, 80 °C, 71% yield; (c) **13**, Pd(OAc)~2~ (0.2 equiv.), D^*t*^BPF (0.3 equiv.), K~2~CO~3~ (2.5 equiv.), NMP, 110 °C, 83% yield; (d) (i) DIBAL-H (3.0 equiv.), toluene, --78 °C; (ii). ClCO~2~Me (3.0 equiv.), Na~2~CO~3~ (3.0 equiv.), DCM--H~2~O (2 : 1 ratio), rt, 64% yield over 2 steps; (e) (i) CF~3~CO~2~H, DCM, 0 °C; (ii) Red-Al (12.0 equiv.), toluene, reflux, 51% yield over 2 steps. Alkyne **13**: *N*-(methoxycarbonyl)-4-(trimethylsilyl)-3-butynylamine.](c5sc00338e-s3){#sch3}

With the successful synthesis of (--)-psychotriasine, we envisioned that other natural products containing the 3α-amino-hexahydropyrrolo\[2,3-*b*\]indole core structure could also be synthesized *via* enantioselective azo-coupling of simple tryptamine derivatives with diazonium salts. However, analogous natural products bearing an extended core structure with the cyclic dipeptide motif, such as (+)-pestalazine B (**4**) and chetomin (**5**), couldn\'t be obtained directly. Baran\'s group reported an elegant approach to form a C--N bond through tryptamine derivatives coupling with aniline in the presence of appropriate oxidants;[@cit3d],[@cit6] however, when this method was attempted with **14**, only a trace amount of the coupling product was obtained. To address this synthetic challenge, we sought to develop a highly diastereoselective azo-coupling of tryptophan derivatives. To obtain better diasteroselectivity of the azo-coupling reaction, we chose compound **14** as a model substrate to screen different solvents and reaction temperatures ([Table 1](#tab1){ref-type="table"}). Using THF as solvent at 15 °C, diastereomer **16** was formed exclusively but only in 14% yield (entry 5). In comparison, utilizing DCE as solvent led to the formation of both diastereomers in a 82% combined yield and high selectivity for **16** (5 : 1, **16** : **15**) (entry 6). Evaluation of a mixed THF--DCE solvent system (entries 8--11) led to an optimized solvent ratio of 1.5 : 1 DCE : THF that promoted a highly diastereoselective azo-coupling to afford **16** in 61% isolated yield and \>25 : 1 diastereoselectivity. The configuration of **16** was confirmed by single crystal X-ray diffraction ([Fig. 3](#fig3){ref-type="fig"}). With this result in hand, we decided to pursue the total synthesis of (+)-pestalazine B (**4**).

###### Diastereoselective azo-coupling of tryptophan derivatives[^*a*^](#tab1fna){ref-type="fn"}

  ![](c5sc00338e-u1.jpg){#ugr1}                                                   
  ------------------------------- ------------------- ------ ------ ------------- -------------------------------------------------
  1                               MeOH                --78   1 h    1 : 1         66%
  2                               MeCN                rt     24 h   ---           ---[^*c*^](#tab1fnc){ref-type="table-fn"}
  3                               Toluene             rt     24 h   1 : 1.5       41%
  4                               THF                 rt     24 h   1 : 1.5       74%
  5                               THF                 15     24 h   Only **16**   14%
  6                               DCE                 15     24 h   1 : 5         82%
  7                               DCE                 rt     24 h   1 : 5         57%
  8                               DCE--THF(1 : 1)     15     48 h   1 : 10        63%
  9                               DCE--THF(1.5 : 1)   15     48 h   \<1 : 25      67% (61[^*d*^](#tab1fnd){ref-type="table-fn"}%)
  10                              DCE--THF(2 : 1)     15     96 h   1 : 20        50%
  11                              DCE--THF(4 : 1)     15     96 h   1 : 4         43%

^*a*^Conditions: **14** (0.1 mmol), PhN~2~BF~4~ (0.11 mmol), K~2~CO~3~ (0.15 mmol) and solvent (1 mL).

^*b*^NMR yield with 1,3,5-trimethoxylbenzene as internal standard.

^*c*^No desired product was detected.

^*d*^Isolated yield.

![Thermal ellipsoid plot of the X-ray structure of compound **16** at the 50% probability level.](c5sc00338e-f3){#fig3}

Our synthesis of (+)-pestalazine B (**4**) began with the diastereoselective azo-coupling using readily available compound **17** ([Scheme 4](#sch4){ref-type="fig"}). Under the standard reaction conditions developed with model compound **14** ([Table 1](#tab1){ref-type="table"}), compound **17** coupled with PhN~2~BF~4~ to afford compound **18** and its diastereomer in a 6 : 1 ratio. Changing the base additive from K~2~CO~3~ to Na~2~CO~3~ while using 0.05 equiv. of **CPA8a** catalyst, compound **18** was obtained with improved diastereoselectivity (\>20 : 1) and 79% yield. With **18** in hand, reductive cleavage of the N0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000N double bond by hydrazine hydrate and Pd/C at 80 °C proceeded smoothly to provide amino compound **19** in 80% yield. The stereochemistry of **19** was consistent with the natural product (confirmed by NOE, see ESI[†](#fn1){ref-type="fn"}). Next, we attempted to construct a C--N bond by coupling between **19** and 1,2-dihalobenzene ([Table 2](#tab2){ref-type="table"}) but with minimal success. We initially tried Pd-catalyzed Buchwald--Hartwig amination using various ligands such as xantphos, BINAP, DPPF, Xphos, Brettphos, DPEphos and indole-derived phosphine ligands. However, only trace amounts of amination product **20** were detected by LCMS (entry 1). We then attempted copper-induced Ullmann coupling utilizing CuI or Cu(OAc)~2~ and ligands such as 2-isobutyrylcyclohexanone or 2,2,6,6-tetramethylheptane-3,5-dione (TMHD). Unfortunately, these yields were still unacceptable (entry 2).[@cit27] Success in such reactions would rely on two factors: selective amination on different amine derivatives and the basicity of the reaction solutions. Traditionally, amination with amides as substrates will proceed more easily than with hindered amines. In addition, the strong base used in the reaction mixtures will result in the racemization of compound **19**. Since hypervalent iodine reagents were widely used for C--N formation under neutral or weakly basic conditions, we decided to pursue this strategy and explore *ortho*-brominated hypervalent iodine reagents for formation of the C--N bond of our target (entries 5--11). Under the optimized conditions of using hypervalent iodine reagent **A3** (5.0 equiv.), Cu(OAc)~2~ (1.0 equiv.), and Na~2~CO~3~ additive (2.0 equiv.), compound **20** was obtained in 45% yield (entry 10) after heating at 80 °C in DMF solvent for 12 hours.[@cit27b] Finally, Larock annulation of **20** and **21** with sterically bulky ligand D^*t*^BPF provided the target molecule (+)-pestalazine B (**4**) in 16.2% overall yield over this 4-step total synthesis (from known compound **17**).[@cit25] The NMR and CD spectral properties of (+)-pestalazine B were in excellent agreement with the natural product.[@cit8a]

![Total synthesis of (+)-pestalazine B (**4**). Reagents and conditions: (a) PhN~2~BF~4~, K~2~CO~3~, **CPA8a**, DCE--THF (1.5 : 1), 0 °C, 79% yield; (b) hydrazine hydrate, Pd/C, EtOH, 85 °C, 80% yield; (c) **A3**, Cu(OTf)~2~, Na~2~CO~3~, DMF, 65 °C, 45% yield, (d) **21**, Pd(OAc)~2~, D^*t*^BPF, Na~2~CO~3~, NMP, 80 °C, 57% yield.](c5sc00338e-s4){#sch4}

###### Selective amination of hindered amine **18**

  ![](c5sc00338e-u2.jpg){#ugr2}                                                                                                            
  ----------------------------------------- -------- ------------------- --------------------------------------- -------------------- ---- -------
  1[^*a*^](#tab2fna){ref-type="table-fn"}   **A1**   Pd~2~dba~3~         *t*-BuONa                               Toluene              80   Trace
  2[^*b*^](#tab2fnb){ref-type="table-fn"}   **A2**   CuI or Cu(OAc)~2~   K~2~CO~3~ or Li~2~CO~3~ or Cs~2~CO~3~   DMF or THF or MeCN   60   Trace
  3                                         **A3**   CuI                 Na~2~CO~3~                              NMP                  80   Trace
  4                                         **A3**   CuI                 Na~2~CO~3~                              DMF                  80   22%
  5                                         **A3**   Cu(OAc)~2~          Na~2~CO~3~                              DMF                  80   34%
  6                                         **A3**   Cu(OAc)~2~          K~2~CO~3~                               DMF                  80   Trace
  7                                         **A3**   Cu(OAc)~2~          Na~3~PO~4~                              DMF                  80   28%
  8                                         **A3**   Cu(OAc)~2~          Na~2~CO~3~                              DMF                  65   42%
  9                                         **A3**   Cu(OAc)~2~          Na~2~CO~3~                              DMF                  50   26%
  10                                        **A3**   Cu(OTf)~2~          Na~2~CO~3~                              DMF                  65   45%
  11                                        **A4**   Cu(OAc)~2~          Na~2~CO~3~                              DMF                  80   33%
  ![](c5sc00338e-u3.jpg){#ugr3}                                                                                                            

^*a*^Ligand tested: xantphos, BINAP, DPPF, Xphos, Brettphos, DPEphos or indole-derived phosphine ligands.

^*b*^Ligand used: 2-isobutyrylcyclohexanone or TMHD.

Conclusions
===========

We have completed the first enantioselective total synthesis of (--)-psychotriasine (**2**) and the enantioselective total synthesis of (+)-pestalazine B (**4**) based on a unified strategy with the newly developed method. In particular, to construct the 3α-amino-hexahydropyrrolo\[2,3-*b*\]indole core structure, a method involving a ligand-controlled enantioselective azo-coupling of tryptamine derivatives by ion-pairing induction or *via* mixed solvent-induced diastereoselective azo-coupling of tryptophan derivatives was applied. This cascade reaction sequence provides a rapid synthetic approach to the related indole alkaloids. In addition, during our synthesis of (+)-pestalazine B (**4**), we utilized a strategy that features a sterically hindered amination process using a hypervalent iodine reagent and copper([i]{.smallcaps}) catalyst. Further total syntheses of other related natural products employing this unified strategy and investigations of their biological activities are underway.
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